Informations sur le produit
Nom :
Mavacoxib
Synonymes :
- 4-(5-(4-Fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
- Benzenesulfonamide, 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-
- Mavacoxib [USAN]
- Pha 739,521
- Trocoxil
- Unii-Yft7X7Sr77
Description :
Mavacoxib is a nonsteroidal anti-inflammatory drug that inhibits the synthesis of prostaglandins. It has been shown to be effective in the treatment of pain, inflammation, and fever. Mavacoxib has been studied for its potential use as an anticancer agent. In vitro studies have demonstrated that mavacoxib inhibits the growth of cancer cells and induces apoptosis at concentrations below those required for inhibition of cyclooxygenase. The mechanism of action is not fully understood but may involve inhibition of DNA synthesis and cell cycle progression. Mavacoxib has shown antimicrobial resistance in some bacterial strains due to its inability to bind to the active site on bacterial enzymes.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
385.34 g/mol
Formule :
C16H11F4N3O2S
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
